Speaker in this video:
Dr Ajay Khopade, VP FR&D, Sun Pharma
Topic: Formulation strategies for complex injectables
Key Highlights:
[1] Complex generics (LAIs, liposomes, nanosystems, combo injectors) are not just ‘copycats’, they require deep scientific innovation
[2] Differentiation must come from delivery systems—not just the molecule
[3] Use regulatory flexibility (e.g., 505(b)(2), EU hybrid path) to bridge between innovation and generic models
[4] Think about device compatibility, usability, and long-term safety in formulation design